Monogram Biosciences has a legacy of developing state-of-the-art, highly reproducible, high-throughput assays in a clinical reference laboratory setting. To meet the growing demand for HCV assays, Monogram has developed its technology platforms to enable evaluation of HCV antiviral drug resistance and other HCV characteristics.
Please contact Monogram regarding technical and pricing information and validation summaries for the following assays:
Antiviral Drug Resistance
Genotype (Gene Sequencing) and Phenotype testing
Clone isolation and analyses
Resistance characterization against virus panels
NS3/4A sequencing is also available for use in the clinic to facilitate patient treatment decisions.
Click here for the GenoSure HCV NS3/4A sample report.
Single Nucleotide Polymorphism (SNP) rs12979860
HCV Viral Load Testing
Please inquire on availability of other SNPs
Abbot Real Time
Click here to view the current status of Monogram’s HCV resistance assays.
Click here for a slide presentation addressing the Monogram Biosciences and LabCorp HCV testing capabilities.